EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook

Tao Chen, Shipeng Li, Dewen Deng, Weiye Zhang, Jianjun Zhang, Zhongyang Shen

Journal of Zhejiang University-SCIENCE B · 2024

DOI: 10.1631/jzus.b2300159 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Zhejiang University-SCIENCE B, 2024. Verfasst von Tao Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: First Central Clinical School, Tianjin Medical University, Tianjin 300192, China. Hauptthemen laut MEDLINE: Interferon Regulatory Factor-1, Liver Diseases, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Tianjin Natural Science Foundation, the National Natural Science Foundation of China, the National Major Scientific Research Instrument Development Project of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon regulatory factor 1 (IRF-1) is a member of the IRF family. It is the first transcription factor to be identified that could bind to the interferon-stimulated response element (ISRE) on the target gene and displays crucial roles in the interferon-induced signals and pathways. IRF-1, as an important medium, has all of the advantages of full cell cycle regulation, cell death signaling transduction, and reinforcing immune surveillance, which are well documented. Current studies indicate that IRF-1 is of vital importance to the occurrence and evolution of multifarious liver diseases, including but not limited to inhibiting the replication of the hepatitis virus (A/B/C/E), alleviating the progression of liver fibrosis, and aggravating hepatic ischemia-reperfusion injury (HIRI). The tumor suppression of IRF-1 is related to the clinical characteristics of liver cancer patients, which makes it a potential indicator for predicting the prognosis and recurrence of liver cancer; additionally, the latest studies have revealed other effects of IRF-1 such as protection against alcoholic/non-alcoholic fatty liver disease (AFLD/NAFLD), cholangiocarcinoma suppression, and uncommon traits in other liver diseases that had previously received little attention. Intriguingly, several compounds and drugs have featured a protective function in specific liver disease models in which there is significant involvement of the IRF-1 signal. In this paper, we hope to propose a prospective research basis upon which to help decipher translational medicine applications of IRF-1 in liver disease treatment. 干扰素调节因子1(IRF-1)是干扰素调节因子家族的重要一员,其主要功能是能够与靶基因上的干扰素刺激反应元件(ISRE)结合,进而在干扰素诱导的信号通路中发挥重要作用。IRF-1作为一种重要的转录因子,在细胞周期调控、细胞死亡信号转导、增强免疫监视等方面具有重要作用。当前研究表明,IRF-1在多种肝脏疾病的发生和发展中发挥至关重要的作用,包括抑制肝炎病的复制、缓解肝纤维化的进展和加重肝缺血再灌注损伤(HIRI)等。IRF-1还作为一种重要的肿瘤抑制因子,在临床上可作为预测肝癌预后和复发的潜在指标。此外,最新的研究还揭示了IRF-1在介导其他肝脏疾病中的潜在作用,如预防酒精性/非酒精性脂肪性肝病,抑制胆管细胞癌的生物学进展,预防细胞排斥反应等。虽然当前的研究极少涉及IRF-1的临床转化领域,但几种化合物和药物似乎可以通过激活IRF-1信号通路,在动物体特定肝脏疾病模型中发挥保护功能。在本文中,我们将综述既往文献以帮助解读IRF-1在肝脏疾病治疗中的研究进展,并提供未来转化医学应用的理论基础。.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Regulatory Factor-1Liver DiseasesLiver NeoplasmsHumansAnimalsSignal TransductionLiver CirrhosisNon-alcoholic Fatty Liver DiseaseReperfusion InjuryCholangiocarcinoma

Stichwörter der Autor:innen

Hepatic ischemia-reperfusion injury (HIRI)Hepatitis virusInterferon regulatory factor (IRF-1)Liver cancerLiver fibrosis

Substanzen

Interferon Regulatory Factor-1IRF1 protein, human

Autor:innen und Institutionen

  • First Central Clinical School, Tianjin Medical University, Tianjin 300192, China.
  • Department of Hepatobiliary Surgery, Henan Provincial People's Hospital, Zhengzhou 450000, China.
  • Key Laboratory of Organ Transplant, Tianjin First Central Hospital, Tianjin 300192, China.
  • Department of Organ Transplant, Tianjin First Central Hospital, Tianjin 300192, China.
  • Research Institute of Transplant Medicine, Nankai University, Tianjin 300192, China.
  • Department of Organ Transplant, Tianjin First Central Hospital, Tianjin 300192, China. yzxzhangjianjun@163.com.

Förderung

  • the Tianjin Natural Science Foundation
  • the National Natural Science Foundation of China
  • the National Major Scientific Research Instrument Development Project of China
  • the Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Zitieren

APA

Chen, T., Li, S., Deng, D., Zhang, W., Zhang, J., & Shen, Z. (2024). Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook. Journal of Zhejiang University-SCIENCE B. https://doi.org/10.1631/jzus.b2300159

Vancouver

Chen T, Li S, Deng D, Zhang W, Zhang J, Shen Z. Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook. Journal of Zhejiang University-SCIENCE B. 2024. doi:10.1631/jzus.b2300159

BibTeX
@article{Chen2024,
  author = {Chen, Tao and Li, Shipeng and Deng, Dewen and Zhang, Weiye and Zhang, Jianjun and Shen, Zhongyang},
  title = {Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook},
  journal = {Journal of Zhejiang University-SCIENCE B},
  year = {2024},
  doi = {10.1631/jzus.b2300159}
}
Kostenlos starten →